Tripp Peake

Venture investor and company builder with proven track record in healthcare and technology. Co-founded LRVHealth in 2000. Led firm's investments in Diameter Health, Extreme Reach, First Light Diagnostics, Optasite (acquired by SBA), Protedyne (acquired by LabCorp), Socially Determined, and Verata. Previously a partner at Kestrel Ventures (Boston-based early stage venture firm), founding CEO of Mass Ventures (UMass-affiliated seed fund), and co-founder/CEO of Science Park Associates (venture development company affiliated with Yale University, Yale Medical School, and Yale New Haven Hospital). B.A. from Dartmouth College and M.B.A. from Yale University.